Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

Visualizar Toda a Documentação

539136

Millipore

Protease Inhibitor Cocktail IV

liquid, for the inhibition of serine proteases, cysteine proteases, aspartic proteases and metalloproteases. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

Sinônimo(s):

Protease inhibitor cocktail

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Código UNSPSC:
12352200
NACRES:
NA.54

Nome do produto

Protease Inhibitor Cocktail Set IV, The Protease Inhibitor Cocktail Set IV controls the activity of Protease. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

Formulário

liquid

fabricante/nome comercial

Calbiochem®

condição de armazenamento

OK to freeze

solubilidade

water: soluble

Condições de expedição

wet ice

temperatura de armazenamento

−20°C

Descrição geral

A cocktail of four protease inhibitors with broad specificity for the inhibition of aspartic-, cysteine-, metallo-, and serine-proteases. Recommended for fungal and yeast cell extracts. Each vial contains 100 mM AEBSF, HCl (Cat. No. 101500), 1.5 mM E-64 (Cat. No. 324890), 2 mM Pepstatin A (Cat. No. 516481), and 500 mM 1,10-Phenanthroline (Cat. No. 516705). Supplied with a data sheet. Note: 1 set = 5 x 1 ml.
The Protease Inhibitor Cocktail Set IV controls the activity of Protease. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

Especificidade

Inhibits a broad spectrum of serine proteases, cysteine proteases, aspartic proteases, and metalloproteases.

Aplicação

Protease Inhibitor Cocktail Set IV, is a cocktail of four protease inhibitors with broad specificity for the aspartic, cysteine, metallo & serine-proteases. Recommended for fungal & yeast cells.

Ações bioquímicas/fisiológicas

Primary Target
aspartic-, cysteine-, metallo-, and serine-proteases
Product does not compete with ATP.

Advertência

Toxicity: Toxic (F)

forma física

In 1 ml DMSO.

Reconstituição

Protease Inhibitor Cocktail Set IV can be used at a 1:100-1:1000 dilution for most applications.

Outras notas

Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.

Informações legais

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Pictogramas

Exclamation markEnvironment
GHS07,GHS09

Palavra indicadora

Warning

Frases de perigo

H302,H315,H319,H410

Classificações de perigo

Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Irrit. 2 - Skin Irrit. 2

Código de classe de armazenamento

10 - Combustible liquids

Classe de risco de água (WGK)

WGK 3

Ponto de fulgor (°F)

188.6 °F - Information refers to the main ingredient.

Ponto de fulgor (°C)

87 °C - Information refers to the main ingredient.

Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Joseph V Geisberg et al.
Current protocols in molecular biology, 128(1), e101-e101 (2019-09-11)
Here we describe CLIP-READS, a technique that combines elements of crosslinking and immunoprecipitation (CLIP) and 3' region extraction and deep sequencing (READS), to provide a genome-wide map of mRNA 3' isoform binding by a given messenger ribonucleoprotein (mRNP). In CLIP-READS
Chao Luo et al.
Oncology letters, 21(2), 161-161 (2021-02-09)
The effects of microRNAs (miRNAs/miRs) on glioblastoma have attracted the attention of researchers in the last 7 years. However, the role of miR-640 and its targeted gene, Slit guidance ligand 1 (SLIT1), in the development of glioblastoma are not yet
Matthew M Seavey et al.
Current protocols in pharmacology, Chapter 5, Unit 5-Unit 5 (2011-09-22)
Systemic Lupus Erythematosus (SLE) is a debilitating and often fatal autoimmune disease that involves multiple organ systems. It can develop for years before being diagnosed. Current treatments for SLE usually involve the use of cytotoxic or immunosuppressive agents that can

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica